Related Experiment Videos
[Late p53 mutation in head and neck oncogenesis]
1Servicio de Otorrinolaringología del Hospital Punta de Europa de Algeciras.
Anales Otorrinolaringologicos Ibero-Americanos
|November 10, 1998
Summary
p53 protein overexpression is common in head and neck cancers, indicating p53 mutation is a late event in oncogenesis. This study analyzed p53 expression in laryngeal and hypopharyngeal tumors and metastases.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- p53 mutations are frequent in human cancers.
- Squamous cell carcinoma of the larynx and hypopharynx are significant head and neck malignancies.
- Understanding the role of p53 in tumorigenesis is crucial for cancer research.
Purpose:
- To investigate the expression of p53 protein in laryngeal and hypopharyngeal squamous cell carcinoma.
- To compare p53 protein levels in tumor tissues, metastases, and normal adjacent mucosa.
- To determine if p53 mutation is an early or late event in head and neck cancer development.
Summary:
- Immunochemistry was used to assess p53 protein expression in 25 patients with squamous cell carcinoma of the larynx and hypopharynx.
- Significantly elevated p53 protein levels were observed in tumor tissues and their corresponding metastases.
- Conversely, normal laryngeal mucosa showed low p53 protein expression.
Impact:
- The findings suggest that p53 mutation is a late-stage event in the oncogenesis of head and neck cancers.
- This research contributes to the understanding of molecular mechanisms underlying head and neck tumorigenesis.
- The study highlights the potential role of p53 as a biomarker in head and neck cancer progression.